Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus (Q45398545)

From Wikidata

Jump to navigation Jump to search

scientific article published on 3 December 2007

Language	Label	Description	Also known as
English	Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus	scientific article published on 3 December 2007

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus (English)

1 reference

Europe PubMed Central

14 December 2017

Simian immunodeficiency virus

0 references

Semliki Forest virus

0 references

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

6

object named as

Bruno Vaslin

1 reference

Europe PubMed Central

14 December 2017

author name string

Frédéric Martinon

1

1 reference

Europe PubMed Central

14 December 2017

Patricia Brochard

2

1 reference

Europe PubMed Central

14 December 2017

Maryline Ripaux

3

1 reference

Europe PubMed Central

14 December 2017

Benoît Delache

4

1 reference

Europe PubMed Central

14 December 2017

Gwenaelle Aurégan

5

1 reference

Europe PubMed Central

14 December 2017

Roger Le Grand

7

1 reference

Europe PubMed Central

14 December 2017

language of work or name

0 references

publication date

3 December 2007

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

26

1 reference

Europe PubMed Central

14 December 2017

4

1 reference

Europe PubMed Central

14 December 2017

532-545

1 reference

Europe PubMed Central

14 December 2017

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Macaque models for AIDS vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Assessing animal models of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Long-lasting protection by live attenuated simian immunodeficiency virus in cynomolgus monkeys: no detection of reactivation after stimulation with a recall antigen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

In vivo protective anti-HIV immune responses in non-human primates through DNA immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

DNA vaccination of macaques with several different Nef sequences induces multispecific T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

CD8+ T-cell responses to different HIV proteins have discordant associations with viral load

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Comparison of the efficacy of early versus late viral proteins in vaccination against SIV

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Heterogeneity of the simian immunodeficiency virus (SIV) specific CD8(+) T-cell response in mucosal tissues during SIV primary infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Improved vaccine protection from simian AIDS by the addition of nonstructural simian immunodeficiency virus genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Vaccine protection from CD4+ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Sustained conservation of CD4+ T cells in multiprotein triple modality-immunized rhesus macaques after intrarectal challenge with simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: comparison of one- versus two-enzyme systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

SYFPEITHI: database for MHC ligands and peptide motifs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Comparison of early plasma RNA loads in different macaque species and the impact of different routes of exposure on SIV/SHIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

A Gag-Pol/Env-Rev SIV239 DNA vaccine improves CD4 counts, and reduce viral loads after pathogenic intrarectal SIV(mac)251 challenge in rhesus Macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Kinetics of Lymphocyte Proliferation during Primary Immune Response in Macaques Infected with Pathogenic Simian Immunodeficiency Virus SIVmac251: Preliminary Report of the Effect of Early Antiviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Induction of bystander T cell proliferation by viruses and type I interferon in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Simian immunodeficiency virus DNA vaccine trial in macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.11.025

1 reference

Europe PubMed Central

14 December 2017

release_kdfsfj6qczcofmu7caj74n7ifu

1 reference

https://api.fatcat.wiki/v0/release/kdfsfj6qczcofmu7caj74n7ifu

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45398545&oldid=2076578454"